French Immunotherapy Partners fight against Autoimmune Disorders – Labiotech.eu (blog)
|
French Immunotherapy Partners fight against Autoimmune Disorders
Labiotech.eu (blog) Servier is offering OSE Immunotherapeutics up to €272M to get hold of an antibody therapy for autoimmune diseases, an area where it will encounter major competitors. OSE Immunotherapeutics, created last May through the merger of OSE Pharma and … |
